BioAmber Inc fka BIOAQ

[Penman1]

Two ideas explaining the secrecy, which seems to be unnecessary.

It's appears to be quite possible that Visolis bought EVERYTHING related to BioAmber, including taking over responsibility for the stock and all outstanding debt.

This is an assumption based on the fact that all the details of the deal are still secret and "under seal." Why? Why would PWC want to keep this secret, and the court assent to this? If the deal was done, why not just say, LCY-Visolis purchased BIOA for $XYZM? No big deal in the broad scheme of things.

Two hypotheses:

1. It may be that all the details are not worked out to the satisfaction of the Court. Isn't there a clause that the purchasing party could still back out of the deal? (I haven't gone back to read all the docs to verify this.)

2. The deal involves a stock purchase (taking over NOLs and all outstanding creditors with the framework of the CCAA), and it may also be that Visolis wants to add YYYM shares to the number to raise additional funds (as part of the presumed agreement with LCY), which will have an impact on the current stock price, which the deal makers seek to keep low at the moment.

Any other explanations that fit the facts?